Drawtex is a wound dressing that uses a technology called LevaFiber to actively pull fluid, debris, and bacteria away from a wound. Unlike traditional dressings that simply absorb moisture, Drawtex works through a combination of capillary action, hydroconductive flow, and electrostatic attraction to draw harmful material out of the wound bed and disperse it through the dressing fabric. It’s FDA-cleared and used on a range of moderate-to-heavy draining wounds, from diabetic foot ulcers to surgical sites.
How Drawtex Works
Most wound dressings are passive. They sit on a wound and soak up whatever fluid reaches them. Drawtex takes a more active approach through its LevaFiber technology, which generates a strong capillary force that pulls wound fluid upward and outward. As that fluid moves, it carries along the problematic material suspended in it: dead tissue, bacteria, and inflammatory compounds called proteases that, when they linger too long, actually slow healing down.
The dressing moves fluid both vertically (away from the wound surface) and horizontally (spreading it across the dressing). This two-directional flow means the dressing can handle a significant volume of drainage without becoming saturated in one spot. If even more absorption is needed, additional layers of Drawtex can be stacked on top, and the fluid will transfer upward into the fresh layers.
One important distinction: Drawtex doesn’t kill bacteria directly. Instead, it works by rapidly removing the nutrient-rich fluid that bacteria feed on. Research published in HMP Global Learning Network found that this “starving” approach can suppress the negative effects of biofilm on wound healing, even when the total number of bacteria in the wound doesn’t drop dramatically. In one study, only 6 out of 10 wounds showed fewer bacteria after four weeks, yet healing still improved. The mechanism appears to be less about sterilizing the wound and more about cutting off the fuel supply that keeps bacterial colonies active and disruptive.
What Wounds It’s Used For
Drawtex is designed for wounds that produce moderate to high levels of drainage or contain dead, devitalized tissue like slough or necrotic material. According to guidance from Wounds UK, specific indications include:
- Venous leg ulcers (used under compression bandaging)
- Pressure ulcers
- Diabetic foot ulcers
- Cavity wounds
- Postoperative wounds
- Partial-thickness burns
- Stoma sites
The common thread is that all of these wound types tend to produce significant exudate and often stall in the healing process because inflammatory byproducts accumulate in the wound bed. By continuously clearing that fluid, Drawtex helps create an environment where new tissue can grow.
Clinical Results
Pilot study data suggests Drawtex can meaningfully outperform standard wound care. In one trial, 50% of patients using Drawtex achieved at least 50% wound closure within four weeks, compared to just 20% of patients receiving standard dressings. Across studies, Drawtex-treated wounds showed mean wound healing scores roughly 40% higher than those treated with conventional dressings over the same timeframe.
These results likely reflect the dressing’s ability to remove inflammatory compounds from the wound environment. Chronic wounds often get stuck in a cycle where excess proteases break down new tissue as fast as the body can build it. By physically pulling those proteases and inflammatory cytokines out of the wound fluid, Drawtex helps interrupt that cycle and lets the body’s natural repair process gain traction.
How It’s Applied
Drawtex is applied directly to the wound bed, where it can conform to the wound’s shape. For deeper cavity wounds, the dressing can be loosely packed into the space. Additional layers can be placed on top for heavily draining wounds, since the hydroconductive action transfers fluid upward through multiple layers. A secondary dressing or bandage is typically placed over the top to hold everything in place.
Dressing change frequency depends on how much fluid the wound produces. Heavily draining wounds may need daily changes initially, while wounds with less exudate can often go longer between changes. As the wound improves and drainage decreases, changes become less frequent. The dressing itself doesn’t contain medications, adhesives, or antimicrobial agents, which means it relies entirely on its physical structure to manage the wound environment.
Regulatory Status
Drawtex received FDA 510(k) clearance in 2006 under the General and Plastic Surgery review panel. It’s classified as a medical device rather than a drug, since it works through physical mechanisms (capillary and electrostatic forces) rather than chemical or pharmaceutical action. This classification means it went through a premarket notification process demonstrating it is substantially equivalent to other cleared wound management devices already on the market.